25Feb2015 The Tularik Alumni: Where Are They Now? /Luke Timmerman/1/All, Cancer, Drugs, People25 Feb 2015 Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.